Metraipolis › archive › dc_befbab8708fb

Characteristics, accessibility and regional equity evaluation of pediatric medicines through National Drug Price Negotiation of China, 2017-2024 — Europe PMC PMID:42158946

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42158946
DOI
10.3389/fphar.2026.1805424
License (as archived)
solo-consultazione
Archived
2026-11-02T18:47:28.178Z
SHA-256 of the archived text
3b85a88f8a46c95f423a5365eed6a6d5be906d6dc32a35de77054e8c139d3b43
Stable URL of this page
https://metraipolis.com/documento/dc_befbab8708fb

How to cite

Characteristics, accessibility and regional equity evaluation of pediatric medicines through National Drug Price Negotiation of China, 2017-2024 — Europe PMC PMID:42158946 — Europe PMC (en), https://europepmc.org/article/MED/42158946 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_befbab8708fb (Metraipolis archive dc_befbab8708fb, sha256 3b85a88f8a46c95f423a5365eed6a6d5be906d6dc32a35de77054e8c139d3b43)
BibTeX
@misc{dcbefbab8708fb,
  title = {Characteristics, accessibility and regional equity evaluation of pediatric medicines through National Drug Price Negotiation of China, 2017-2024 — Europe PMC PMID:42158946},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42158946},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_befbab8708fb; sha256 3b85a88f8a46c95f423a5365eed6a6d5be906d6dc32a35de77054e8c139d3b43},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42158946. Agents can read the archived copy with the MCP tool read_document.